RESUMO
Objective To observe the clinical efficacy of herb-partitioned fire therapy in treating stomachache due to cold-deficiency. Method Sixty patients with stomachache due to cold-deficiency were randomized into a treatment group and a control group, 30 cases each. The control group was intervened by Western and Chinese medications, based on which, the treatment group was given herb-partitioned fire therapy. The clinical efficacies of the two groups were observed, as well as the symptoms scores before and after the treatment. Result There was a significant difference in the clinical efficacy between the two groups (P<0.01). The symptoms scores dropped after the intervention in both groups, and the score in the treatment group was significantly lower than that in the control group (P<0.01). Conclusion Herb-partitioned fire therapy plus medication is effective in treating stomachache due to cold-deficiency, and it can produce a more significant efficacy than medication alone.
RESUMO
Objective To compare the clinical effects of uniportal and triportal video-assisted thoracoscopic lobectomy in treatment of non-small cell lung cancer. Methods From January 2013 to November 2016, 141 non-small cell lung cancer patients underwent uniportal video-assisted thoracoscopic lobectomy (52 cases, uniportal group), and 89 lung cancer patients underwent triportal video-assisted thoracoscopic lobectomy (triportal group). All the cases were performed by the same surgeon. The operative time, intraoperative blood loss, lymph node dissection number, chest drainage duration, postoperative total drainage volume, hospital stay and postoperative complications were recorded and compared between the two groups. Results There were no statistical differences in lymph node dissection number, chest drainage duration, postoperative total drainage volume and postoperative complications after surgery between the uniportal group and the triportal group (P > 0.05). The mean operative time for the uniportal group and the triportal group was (196.1 ± 19.6) minutes and (162.7 ± 18.9) minutes, respectively, P = 0.000. The mean intraoperative blood loss for the uniportal group and the triportal group was (100.3 ± 13.6) ml and (176.5 ± 15.9) ml, respectively, P = 0.000. The hospital stay for the uniportal group and the triportal group was (7.5 ± 1.7) days and (9.2 ± 1.3) days, P = 0.000. Conclusion Uniportal video-assisted thoracoscopic lobectomy can achieve the same effect as triportal video-assisted thoracoscopic lobectomy, though it increased the operation time, however, it has the advantage of less surgical damage to chest wall muscles, intercostal nerves or blood vessels, shorten the postoperative hospital stay, and can be used as a safe and reliable radical surgery for non-small cell lung cancer.
RESUMO
Objective To compare the clinical effects of uniportal and triportal video-assisted thoracoscopic lobectomy in treatment of non-small cell lung cancer. Methods From January 2013 to November 2016, 141 non-small cell lung cancer patients underwent uniportal video-assisted thoracoscopic lobectomy (52 cases, uniportal group), and 89 lung cancer patients underwent triportal video-assisted thoracoscopic lobectomy (triportal group). All the cases were performed by the same surgeon. The operative time, intraoperative blood loss, lymph node dissection number, chest drainage duration, postoperative total drainage volume, hospital stay and postoperative complications were recorded and compared between the two groups. Results There were no statistical differences in lymph node dissection number, chest drainage duration, postoperative total drainage volume and postoperative complications after surgery between the uniportal group and the triportal group (P > 0.05). The mean operative time for the uniportal group and the triportal group was (196.1 ± 19.6) minutes and (162.7 ± 18.9) minutes, respectively, P = 0.000. The mean intraoperative blood loss for the uniportal group and the triportal group was (100.3 ± 13.6) ml and (176.5 ± 15.9) ml, respectively, P = 0.000. The hospital stay for the uniportal group and the triportal group was (7.5 ± 1.7) days and (9.2 ± 1.3) days, P = 0.000. Conclusion Uniportal video-assisted thoracoscopic lobectomy can achieve the same effect as triportal video-assisted thoracoscopic lobectomy, though it increased the operation time, however, it has the advantage of less surgical damage to chest wall muscles, intercostal nerves or blood vessels, shorten the postoperative hospital stay, and can be used as a safe and reliable radical surgery for non-small cell lung cancer.